Skip to content

Mesa Laboratories MLAB Return on equity

Return on equity at other companies

3M logo
3MMMM
72.1%-21.3pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
Danaher logo
DanaherDHR
7.1%-0.1pp
STERIS logo
STERISSTE
11.3%+1.8pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
-6%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Calculated from Mesa Laboratories’s reported figures.

Based on trailing twelve months.

The official record: Mesa Laboratories’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's return on equity?
Mesa Laboratories (MLAB) reported return on equity of 2.2% in Q4 2025.
How has Mesa Laboratories's return on equity changed year-over-year?
Mesa Laboratories's return on equity increased by 102.4% year-over-year, from -89.4% to 2.2%.
What is the long-term trend for Mesa Laboratories's return on equity?
Over 2 years (2021 to 2025), Mesa Laboratories's return on equity has grown at a 11.2% compound annual growth rate (CAGR), from 1% to -1.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.